CFAGX
Price
$37.46
Change
+$0.11 (+0.29%)
Updated
Sep 4 closing price
Net Assets
113.98M
JDMRX
Price
$131.06
Change
+$0.81 (+0.62%)
Updated
Sep 3 closing price
Net Assets
21.66B
Interact to see
Advertisement

CFAGX vs JDMRX

CFAGX vs JDMRX Comparison Chart in %
View a ticker or compare two or three
VS
CFAGX vs. JDMRX commentary
Sep 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CFAGX is a Hold and JDMRX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JDMRX has more cash in the bank: 21.7B vs. CFAGX (114M). CFAGX pays higher dividends than JDMRX: CFAGX (0.07) vs JDMRX (0.00). CFAGX was incepted earlier than JDMRX: CFAGX (32 years) vs JDMRX (17 years). JDMRX (1.41) is less costly to investors than CFAGX (0.84). CFAGX is a more actively managed with annual turnover of: 74.00 vs. JDMRX (17.00). CFAGX has a lower initial minimum investment than JDMRX: CFAGX (1000) vs JDMRX (2500). JDMRX annual gain was more profitable for investors over the last year : 0.65 vs. CFAGX (-21.07). JDMRX return over 5 years is better than : -21.11 vs. CFAGX (-37.24).
CFAGXJDMRXCFAGX / JDMRX
Total Expense Ratio0.841.4160%
Annual Report Gross Expense Ratio0.841.4160%
Fund Existence32 years17 years-
Gain YTD3.6927.70948%
Front LoadN/AN/A-
Min. Initial Investment1000250040%
Min. Initial Investment IRAN/AN/A-
Net Assets114M21.7B1%
Annual Yield % from dividends0.070.00-
Returns for 1 year-21.070.65-3,227%
Returns for 3 years-13.0010.39-125%
Returns for 5 years-37.24-21.11176%
Returns for 10 years5.9542.6814%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SIDNX16.60N/A
N/A
Hartford Schroders Intl Multi-Cp Val I
HBGHX16.44N/A
N/A
Hartford Healthcare HLS IB
FBTDX183.00N/A
N/A
Franklin Biotechnology Discovery C
OIEQX29.12N/A
N/A
JPMorgan Equity Income R4
VYGLX13.08N/A
N/A
Voya Global Income & Growth I